The Future of Lung Disease Interception with ...

To capture the breadth of the past year's discussions, HCPLive presents this Lungcast 2025 recap episode, highlighting a selection of standout conversations from across the series. While far from exhaustive, this collection reflects the themes, questions, and breakthroughs that d ...  Show more

In this episode, we are joined by Elizabeth Cerceo, MD to explore the critical role of resilience and sustainability in the healthcare industry. The discussion highlights how healthcare systems can adapt to crises like extreme weather events and pandemics while maintaining qualit ...  Show more

Dr. Lauren Kim discusses the use of normalized join-count in predicting emphysema progression with Dr. Sukhraj Virdee and Dr. Miranda Kirby.  CT Chest Imaging Using Normalized Join-Count:Predicting Emphysema Progression in the CanCOLD Study. Virdee et al. Radiology 2024; 312(1):e ...  Show more

Story at-a-glance Chronic respiratory diseases remain profitable but poorly treated, subjecting patients to expensive healthcare, impaired stamina, and painful decline DMSO is an "umbrella remedy" treating diverse ailments through therapeutic properties including reducing inflamm ...  Show more

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ...  Show more

Kieran Walsh, clinical director at BMJ, asks Matt Castleden, GP and editor for BMJ Best Practice and BMJ Learning, to summarise the latest clinical guidance in acute medicine. Dr Castleden updates us on recent recommendations on pulmonary embolism, and also acute respiratory dist ...  Show more